Strategies of targeting KRAS, challenging drug target.
Sign Up to like & getrecommendations! Published in 2022 at "Current pharmaceutical design"
DOI: 10.2174/1381612828666220506144046
Abstract: In the developed world, cancer is the most common cause of death. Among the 36 human genes of the RAS family, KRAS, NRAS, and HRAS play a prominent role in human cancer. KRAS belongs to… read more here.
Keywords: kras challenging; challenging drug; strategies targeting; targeting kras ... See more keywords
Strategies for targeting CIB1, a challenging drug target.
Sign Up to like & getrecommendations! Published in 2022 at "Current pharmaceutical design"
DOI: 10.2174/1381612828666220728101812
Abstract: Breast cancer is common malignancy in women which is diverse disease. In women, 287,850 and in male 2710 cases are reported in 2022 reported by WHO. Triple negative breast cancer (TNBC), a subtype of breast… read more here.
Keywords: drug target; breast cancer; challenging drug; cancer ... See more keywords